查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1874002

心臟復健市場

Cardiac Rehabilitation Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

預計心臟復健市場將從 2024 年的 24.5 億美元成長到 2031 年的 34 億美元，2031 年至 2031 年的年複合成長率(CAGR) 為 6.7%。推動該市場成長的關鍵趨勢包括心臟復健設備相關技術的進步。

心臟復健市場分析

預計未來十年，各公司推出的新產品將推動心臟復健服務需求的成長。例如，OmniVR 的「虛擬復健系統」提供可互動、可客製化的活動，支援坐姿和站姿兩種復健姿勢。該系統透過整合能夠鍛鍊記憶力和執行功能的任務，幫助患者克服認知障礙。這種虛擬心臟復健方法能夠提高患者的參與度和愉悅感，進而改善復健效果。

心臟復健市場概覽

心臟復健計畫能有效降低醫院再入院率。 「心跳」（HeartBeat）就是一個例子，它是一項在社區內運作的綜合性門診心臟復健服務。復健課程由合格的醫療專業人員、諮商師和全科醫生共同進行，他們會向計畫組織者提供回饋，篩選合適的患者，鼓勵患者參與，協助藥物管理，並監測和治療心血管疾病（CVD）風險因素。此類門診計畫對於應對未來幾年心血管疾病發生率的上升至關重要。

戰略洞察

心臟復健市場的促進因素與機遇

心血管疾病的增加有利於市場成長

根據美國心臟協會報告，心血管疾病（CVD）是美國首要死因，2020年造成928,741人死亡。因此，心血管疾病的日益增多凸顯了心臟復健對於心臟病發作、心臟衰竭以及其他需要手術或藥物治療的心臟疾病患者的重要性。心血管疾病盛行率的不斷上升是推動心臟復健服務需求成長的重要因素，從而提升了全球市場佔有率。

虛擬心臟復健的機遇

居家或線上心臟復健（CR）計畫能夠有效消除患者獲得傳統中心式心臟復健服務的障礙，提供安全有效的服務。這些線上計畫通常提供多種運動選擇、每週簡訊、心臟健康線上討論、線上諮詢以及包括冥想課程在內的專業工作坊。例如，凱撒醫療集團（Kaiser Permanente）於2024年6月啟動了一項線上心臟復健項目，招募了超過2,300名患者，使其成為美國規模最大的計畫之一。此計畫使參與者在同一年因心臟相關疾病再次入院的比例低於2%。因此，從2021年到2031年，線上心臟復健市場蘊藏著巨大的成長潛力。

心臟復健市場細分分析

心臟復健市場分析按類型、病因、疾病類型、類別和最終用戶進行細分。

  • 按產品分類，市場包括心率監測器、穩定球、跑步機、橢圓機、血壓監測器、固定式自行車等，其中跑步機在 2023 年佔據最大的市場佔有率。
  • 按應用領域分類，市場分為血管成形術、冠狀動脈疾病、心肌病變、膽固醇管理、糖尿病和肺移植，其中血管成形術在 2023 年將成為領先細分市場。
  • 按最終用戶分類，市場分為醫院和診所、專科醫院、家庭醫療保健、心臟復健中心和其他，其中心臟復健中心在 2023 年佔據了市場佔有率的主導地位。

心臟復健市場的地理分析

心臟復健市場的地理分析分為五個區域：北美、亞太地區、歐洲、中東和非洲、南美和中美洲。

北美市場佔據主導地位，其中美國市場佔有率最大，這得益於其擁有頂尖的心臟復健服務提供者以及政府對虛擬復健計畫的支持。預計亞太地區未來幾年將實現最高的成長率。

心臟復健市場報告範圍

心臟復健市場的最新發展

心臟復健市場評估是基於從一手和二手研究中收集的定性和定量資料，包括重要的企業出版物、協會資料和資料庫。該市場的主要發展趨勢包括：

  • Lupin Digital Health推出了全球首個針對心臟科醫生的「數位療法證書」。他們的「Lyfe」計畫是印度首個經臨床驗證的遠距心臟復健計劃，已被證實能夠改善心臟健康，並提高心血管疾病患者的生活品質。 （資料來源：Lupin公司網站，2024年1月）

心臟復健市場報告的覆蓋範圍和交付成果

這份題為《心臟復健市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：

  • 全球、區域和國家層面所有關鍵細分市場的市場規模和預測。
  • 市場趨勢和動態，包括促進因素、限制因素和主要機會。
  • 詳細的PEST/波特五力模型和SWOT分析。
  • 市場分析涵蓋關鍵趨勢、全球和區域框架、主要參與者、法規和最新發展。
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展。
  • 深入的公司概況。

目錄

第1章：引言

第2章：心臟復健市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：全球心臟復健市場及市場概況

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 歐洲和PEST分析
    • 亞太地區及PEST分析
    • 中東和非洲 (MEA) 及 PEST 分析
    • 南美洲和中美洲（SCAM）及PEST分析
  • 專家意見

第5章：心臟復健市場及主要市場動態

  • 市場促進因素
    • 心血管疾病發生率上升
    • 遠距心臟復健的普及應用日益廣泛
  • 市場限制
    • 心臟復健設備成本高昂
  • 市場機遇
    • 政府支持舉措
  • 未來趨勢
    • 技術先進的心臟復健產品日益增多
  • 影響分析

第6章：心臟復健市場及全球分析

  • 全球心臟復健市場收入預測與分析
  • 全球心臟復健市場（依地域分類）－預測與分析
  • 關鍵參與者的市場定位

第7章：心臟復健市場分析及產品分類

  • 概述
  • 心臟復健市場收入佔有率（按產品分類）（2020 年和 2031 年）
  • 心率監測器
  • 穩定球
  • 跑步機
  • 划船者
  • 橢圓機
  • 血壓監測儀
  • 固定式自行車
  • 其他

第8章：心臟復健市場分析及應用

  • 概述
  • 按應用領域分類的心臟復健市場收入佔有率（2020 年和 2031 年）
  • 血管成形術
  • 冠狀動脈疾病
  • 心肌病變
  • 膽固醇管理
  • 糖尿病
  • 肺移植

第9章：心臟復健市場及最終用戶

  • 概述
  • 2020 年及 2031 年心臟復健市場（依配銷通路分類）(%)
  • 醫院和診所
    • 概述
    • 醫院及診所：心臟復健市場及收入預測（至2031年）
  • 家庭醫療保健
    • 概述
    • 家庭醫療保健：心臟復健市場及收入預測（至2031年）
  • 專科醫院
    • 概述
    • 專科醫院：心臟復健市場及收入預測（至2031年）
  • 心臟復健中心
    • 概述
    • 心臟復健中心：心臟復健市場及收入預測（至2031年）
  • 其他
    • 概述
    • 其他：心臟復健市場及收入預測（至2031年）

第10章：全球心臟復健市場及地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第11章：新冠肺炎疫情對全球心臟復健市場的影響

  • 北美洲
  • 歐洲
  • 亞太
  • 中東和非洲
  • 南美洲和中美洲

第12章：心臟復健市場及產業概況

  • 概述
  • 市場中各公司採取的成長策略（%）
  • 有機發展
    • 概述
  • 無機物發展
    • 概述

第13章：公司簡介

  • Halma plc
  • OMRON Corporation
  • AVECINNA
  • Koninklijke Philips N.V.
  • General Electric Company
  • Core Health and Fitness, LLC
  • Peloton Interactive, Inc.
  • Resideo Technologies, Inc
  • ergoline GmbH
  • HealthCare International
簡介目錄
Product Code: TIPHE100000851

The cardiac rehabilitation market is anticipated to grow from US$ 2.45 billion in 2024 to US$ 3.4 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.7% during the period from 2031 to 2031. Key trends driving this market include advancements in technology related to cardiac rehabilitation devices.

Analysis of the Cardiac Rehabilitation Market

New product introductions by companies are expected to boost the demand for cardiac rehabilitation services over the next decade. For instance, OmniVR's "Virtual Rehabilitation System" features interactive, customizable activities for both seated and standing positions. This system addresses cognitive impairments in patients by incorporating tasks that engage memory and executive functions. The virtual approach to cardiac rehabilitation enhances patient engagement and enjoyment, leading to improved functional outcomes.

Overview of the Cardiac Rehabilitation Market

Cardiac rehabilitation programs are effective in lowering hospital readmission rates. An example is "HeartBeat," a comprehensive outpatient cardiac rehabilitation service that operates within the community. Sessions are conducted by qualified health professionals, counselors, and general practitioners who provide feedback to program organizers, select appropriate patients, encourage attendance, assist with medication management, and monitor and treat cardiovascular disease (CVD) risk factors. Such outpatient programs are crucial in managing the increasing rates of cardiovascular diseases in the coming years.

Strategic Insights

Drivers and Opportunities in the Cardiac Rehabilitation Market

Increasing Cardiovascular Diseases Favoring Market Growth

As reported by the American Heart Association, cardiovascular disease (CVD) was the leading cause of death in the US, resulting in 928,741 fatalities in 2020. Consequently, the rise in cardiovascular diseases underscores the importance of cardiac rehabilitation for individuals recovering from heart attacks, heart failure, and other cardiac issues requiring surgical or medical intervention. This growing prevalence of cardiovascular diseases is a significant driver of demand for cardiac rehabilitation services, thereby enhancing the global market share.

Opportunities in Virtual Cardiac Rehabilitation

Home-based or virtual cardiac rehabilitation (CR) programs can effectively eliminate barriers to accessing traditional center-based CR, providing safe and beneficial services. These virtual programs typically offer exercise options, weekly newsletters, live discussions on heart health, virtual consultations, and specialized workshops, including meditation sessions. For example, Kaiser Permanente launched a virtual cardiac rehabilitation program in June 2024, enrolling over 2,300 patients, making it one of the largest programs in the US. This initiative resulted in cardiac-related hospital readmissions for participants being less than 2% in the same year. Thus, virtual cardiac rehabilitation presents a significant opportunity for market growth from 2021 to 2031.

Segmentation Analysis of the Cardiac Rehabilitation Market

The cardiac rehabilitation market analysis is segmented based on type, cause, disorder type, category, and end user.

  • By product, the market includes heart rate monitors, stabilization balls, treadmills, elliptical trainers, blood pressure monitors, stationary bicycles, and others, with the treadmill segment holding the largest market share in 2023.
  • By application, the market is divided into angioplasty, coronary artery disease, cardiomyopathy, cholesterol management, diabetes, and lung transplant, with angioplasty being the leading segment in 2023.
  • By end user, the market is categorized into hospitals & clinics, specialty hospitals, home healthcare, cardiac rehabilitation centers, and others, with cardiac rehabilitation centers dominating the market share in 2023.

Geographical Analysis of the Cardiac Rehabilitation Market

The geographic analysis of the Cardiac Rehabilitation market is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America leads the market, with the US holding the largest share due to the presence of top cardiac rehabilitation service providers and government support for virtual rehabilitation programs. The Asia Pacific region is expected to experience the highest growth rate in the coming years.

Scope of the Cardiac Rehabilitation Market Report

Recent Developments in the Cardiac Rehabilitation Market

The Cardiac Rehabilitation market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Notable developments in the market include:

  • Lupin Digital Health has launched the world's first "Digital Therapeutics Certificate" for cardiologists. Their program "Lyfe" is India's first clinically validated remote cardiac rehabilitation initiative, proven to enhance heart health and improve the quality of life for cardiovascular patients. (Source: Lupin, Company Website, January 2024)

Coverage and Deliverables of the Cardiac Rehabilitation Market Report

The report titled "Cardiac Rehabilitation Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key segments.
  • Market trends and dynamics, including drivers, restraints, and key opportunities.
  • Detailed PEST/Porter's Five Forces and SWOT analysis.
  • Market analysis covering key trends, global and regional frameworks, major players, regulations, and recent developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
  • In-depth company profiles.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cardiac Rehabilitation Market and By Product
    • 1.3.2 Global Cardiac Rehabilitation Market and By Application
    • 1.3.3 Global Cardiac Rehabilitation Market and By End User
    • 1.3.4 Global Cardiac Rehabilitation Market and By Geography

2. Cardiac Rehabilitation Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cardiac Rehabilitation Market and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 Asia Pacific and PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) and PEST Analysis
    • 4.2.5 South and Central America (SCAM) and PEST Analysis
  • 4.3 Expert Opinions

5. Cardiac Rehabilitation Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidences of Cardiovascular Diseases
    • 5.1.2 Growing Adoption of Tele-Cardiac Rehabilitation
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Cardiac Rehabilitation Equipment
  • 5.3 Market Opportunities
    • 5.3.1 Supportive Government Initiatives
  • 5.4 Future Trends
    • 5.4.1 Rise in Technologically Advanced Cardiac Rehabilitation Products
  • 5.5 Impact Analysis

6. Cardiac Rehabilitation Market and Global Analysis

  • 6.1 Global Cardiac Rehabilitation Market Revenue Forecast and Analysis
  • 6.2 Global Cardiac Rehabilitation Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Cardiac Rehabilitation Market Analysis and By Products

  • 7.1 Overview
  • 7.2 Cardiac Rehabilitation Market Revenue Share, by Products (2020 and 2031)
  • 7.3 Heart Rate Monitors
    • 7.3.1 Overview
    • 7.3.2 Heart Rate Monitors: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.4 Stabilization Balls
    • 7.4.1 Overview
    • 7.4.2 Stabilization Balls: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.5 Treadmill
    • 7.5.1 Overview
    • 7.5.2 Treadmill: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.6 Rower
    • 7.6.1 Overview
    • 7.6.2 Rower: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.7 Elliptical Trainer
    • 7.7.1 Overview
    • 7.7.2 Elliptical Trainer: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.8 Blood Pressure Monitor
    • 7.8.1 Overview
    • 7.8.2 Blood Pressure Monitor: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.9 Stationary Bicycle
    • 7.9.1 Overview
    • 7.9.2 Stationary Bicycle: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

8. Cardiac Rehabilitation Market Analysis and By Application

  • 8.1 Overview
  • 8.2 Cardiac Rehabilitation Market Revenue Share, by Application (2020 and 2031)
  • 8.3 Angioplasty
    • 8.3.1 Overview
    • 8.3.2 Angioplasty: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.4 Coronary Artery Disease
    • 8.4.1 Overview
    • 8.4.2 Coronary Artery Disease: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.5 Cardiomyopathy
    • 8.5.1 Overview
    • 8.5.2 Cardiomyopathy: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.6 Cholesterol Management
    • 8.6.1 Overview
    • 8.6.2 Cholesterol Management: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.7 Diabetes
    • 8.7.1 Overview
    • 8.7.2 Diabetes: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.8 Lung Transplant
    • 8.8.1 Overview
    • 8.8.2 Lung Transplant: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

9. Cardiac Rehabilitation Marketand By End User

  • 9.1 Overview
  • 9.2 Cardiac Rehabilitation Market, by Distribution Channel, 2020 and 2031 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.4 Home Healthcare
    • 9.4.1 Overview
    • 9.4.2 Home Healthcare: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.5 Specialty Hospitals
    • 9.5.1 Overview
    • 9.5.2 Specialty Hospitals: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.6 Cardiac Rehabilitation Centers
    • 9.6.1 Overview
    • 9.6.2 Cardiac Rehabilitation Centers: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

10. Global Cardiac Rehabilitation Market and Geographical Analysis

  • 10.1 North America: Cardiac Rehabilitation Market
    • 10.1.1 Overview
    • 10.1.2 North America: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
    • 10.1.3 North America: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.1.4 North America: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.1.5 North America: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
    • 10.1.6 North America: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.1.6.1 US: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.1.1 US: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.1.2 US: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.1.3 US: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.1.4 US: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.1.6.2 Canada: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.2.1 Canada: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.2.2 Canada: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.2.3 Canada: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.2.4 Canada: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.1.6.3 Mexico: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.3.1 Mexico: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.3.2 Mexico: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.3.3 Mexico: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.3.4 Mexico: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.2 Europe: Cardiac Rehabilitation Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.2.3 Europe: Cardiac Rehabilitation Market, by Device, 2024 and 2031 (USD Million)
    • 10.2.4 Europe: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
    • 10.2.5 Europe: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
    • 10.2.6 Europe: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.2.6.1 Germany: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.1.1 Germany: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.1.2 Germany: Cardiac rehabilitation Market, by Product 2024 and 2031 (USD Million)
        • 10.2.6.1.3 Germany: Cardiac rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.1.4 Germany: Cardiac rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.2 UK: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.2.1 UK: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.2.2 UK: Cardiac Rehabilitation Market, Product, 2024 and 2031 (USD Million)
        • 10.2.6.2.3 UK: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.2.4 UK: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.3 France: Cardiac rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.3.1 France: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.3.2 France: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.3.3 France: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.3.4 France: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.4 Italy: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.4.1 Italy: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.4.2 Italy: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.4.3 Italy: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.4.4 Italy: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.2.6.5 Spain: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.5.1 Spain: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.5.2 Spain: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.5.3 Spain: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.5.4 Spain: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.2.6.6 Rest of Europe: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.6.1 Rest of Europe: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.6.2 Rest of Europe: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.6.3 Rest of Europe: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.6.4 Rest of Europe: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.3 Asia Pacific: Cardiac Rehabilitation Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.3.3 Asia Pacific: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.3.4 Asia Pacific: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.3.5 Asia Pacific: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
    • 10.3.6 Asia Pacific: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.3.6.1 Japan: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.1.1 Japan: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.1.2 Japan: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.1.3 Japan: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.1.4 Japan: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.2 China: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.2.1 China: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.2.2 China: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.2.3 China: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.2.4 China: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.3 India: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.3.1 India: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.3.2 India: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.3.3 India: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.3.4 India: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.4 South Korea: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.4.1 South Korea: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.4.2 South Korea: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.4.3 South Korea: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.4.4 South Korea: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.5 Australia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.5.1 Australia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.5.2 Australia: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.5.3 Australia: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.5.4 Australia: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.6 Rest of Asia Pacific: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.6.1 Rest of Asia Pacific: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.6.2 Rest of Asia Pacific: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.4 Middle East and Africa: Cardiac Rehabilitation Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.4.3 Middle East and Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.4.4 Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.4.5 Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.4.6 Middle East and Africa: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.4.6.1 Saudi Arabia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.1.1 Saudi Arabia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.1.2 Saudi Arabia: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.1.3 Saudi Arabia: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.1.4 Saudi Arabia: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.2 UAE: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.2.1 UAE: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.2.2 UAE: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.2.3 UAE: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.2.4 UAE: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.3 South Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.3.1 South Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.3.2 South Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.3.3 South Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.3.4 South Africa: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.4 Rest of Middle East and Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.4.1 Rest of Middle East and Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.4.2 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.4.3 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.4.4 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
  • 10.5 South and Central America: Cardiac Rehabilitation Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.5.3 South and Central America: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
    • 10.5.4 South and Central America: Cardiac Rehabilitation Market, by Application, 2019 -2031 (USD Million)
    • 10.5.5 South and Central America: Cardiac Rehabilitation Market, by End User, 2019 -2031 (USD Million)
    • 10.5.6 South and Central America: Cardiac Rehabilitation Market Share by Country and 2020 and 2031, (%)
      • 10.5.6.1 Brazil: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.1.1 Brazil: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.1.2 Brazil: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.1.3 Brazil: Cardiac Rehabilitation Market, by Application, 2019-2031 (USD Million)
        • 10.5.6.1.4 Brazil: Cardiac Rehabilitation Market, by End User, 2019-2031 (USD Million)
      • 10.5.6.2 Argentina: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.2.1 Argentina: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.2.2 Argentina: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.2.3 Argentina: Cardiac Rehabilitation Market, by Application, 2019 -2031 (USD Million)
        • 10.5.6.2.4 Argentina: Cardiac Rehabilitation Market, by End User, 2019 -2031 (USD Million)
      • 10.5.6.3 Rest of South and Central America: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.3.1 Rest of South and Central America: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.3.2 Rest of South and Central America: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.3.3 Rest of South and Central America: Cardiac Rehabilitation Market, by Application, 2019-2031 (USD Million)
        • 10.5.6.3.4 Rest of South and Central America: Cardiac Rehabilitation Market, by End User, 2018-2027 (USD Million)

11. Impact Of COVID-19 Pandemic on Global Cardiac Rehabilitation Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Cardiac Rehabilitation MarketandIndustry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Halma plc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 OMRON Corporation
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 AVECINNA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Koninklijke Philips N.V.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 General Electric Company
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Core Health and Fitness, LLC
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Peloton Interactive, Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Resideo Technologies, Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 ergoline GmbH
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 HealthCare International
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments